The invention discloses application of a
stem cell exosome in treating depression-like behaviors caused by high-altitude hypoxia, and belongs to the technical field of
biomedicine. The
stem cell exosome is an
exosome derived from human
umbilical cord mesenchymal stem cells, and is used for drugs for preventing and / or treating depression-like behaviors caused by high-altitude hypoxia. The exosome can effectively improve depression-like core behavior symptoms caused by high-altitude hypoxia by regulating a brain-intestinal axis; the method starts from remodeling intestinal
flora so as to influence the intracerebral
metabolite spectrum, and finally plays a role in
neuroprotection by regulating and controlling a 5-HT6 / cAMP-PKA key
signal channel. In addition, the combination of the hUC-MSC-exo and probiotics shows synergistic
interaction potential, and a potential
treatment strategy which is novel in mechanism, remarkable in effect and high in safety is provided for the field.